iNOS is associated with tumorigenicity as an independent prognosticator in human intrahepatic cholangiocarcinoma

Background Inducible nitric oxide synthase (iNOS) has supposed to implicate in inflammation, infection, liver cirrhosis, and neoplastic diseases. This study was designed to explore the biological and clinical function of iNOS in intrahepatic cholangiocarcinoma (ICC).